IMC-003(ImmuneOnco Biopharmaceuticals)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameIMC-003(ImmuneOnco Biopharmaceuticals)
Drug Alias NameIMM72IMM-72IMC-003IMC-003(ImmuneOnco Biopharmaceuticals)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionActivin receptor type-2A modulators
TargetsActivin receptor type-2A
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYiming Kell Biomedical Technology (Shanghai) Co LtdImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A